Please login to the form below

Not currently logged in
Email:
Password:

TiGenix appoints Dr Marie Paule Richard

She takes on role as chief medical officer and brings experience from Aicuris and Crucell

Dr Marie Paule Richard appointed at TiGenixBelgium-based cell therapy company TiGenix has appointed Dr Marie Paule Richard as its new chief medical officer.

An immunologist with over 25 years of experience in the global biopharmaceutical industry, Richard has previously served as chief medical officer at Aicuris in Germany and vice president of clinical development, pharmacovigilance and medical affairs at Crucell in Switzerland.

She joins TiGenix from PharmaBioDev, the consultancy she led, and also brings experience to the role from GlaxoSmithKline and Sanofi.

In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is in phase III trials for complex perianal fistulas in Crohn's disease.

Eduardo Brave, chief executive officer at TiGenix, said: “The whole focus of TiGenix is the successful clinical development, regulatory approval and future commercialisation of the new products in its development pipeline.

“We are very fortunate to have biopharma development, regulatory and commercialisation heavyweight Marie Paule joining the TiGenix management team. She brings a wealth of experience and ability in areas which will be key for the success of the company in the near future.”

2nd September 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....